Jaisim Shah

Jaisim Shah is President, Chief Executive Officer & Director at Scilex Pharmaceuticals, Inc. since 2016.
Former positions include President, Chief Executive Officer & Director at Semnur, Inc. from 2013 to 2019 and at Semnur Pharmaceuticals, Inc. from 2025 to 2026.
Director roles were held at Acucela, Inc., Celularity, Inc. (2017–2021), Scilex Holding Co. (2025), Scilex, Inc. (2024–2025), and Sorrento Therapeutics, Inc. (2014–2023).
Other former roles include Vice President-Global Marketing at Bristol Myers Squibb Co. (1997–2000), Chief Business Officer & Senior Vice President at LadRx Corp., Senior VP-Marketing & Medical Affairs at Protein Design Labs, Inc. (2000–2006), Chief Business Officer at Pulmatrix Operating Co., Inc., President at Azelon Pharmaceuticals, Inc., Chief Business Officer & Senior Vice President at Abbott Biotherapeutics Corp.
(2008–2009), Chief Business Officer & Senior Vice President at PDL BioPharma, Inc. (2000–2008), and Chief Business Officer & Senior Vice President at Elevation Pharmaceuticals, Inc. (2011–2012).
Education includes graduate studies at the University of Akron and an MBA from the University of Oklahoma.